+Search query
-Structure paper
Title | Discovery of Potent, Orally Bioavailable, Tricyclic NLRP3 Inhibitors. |
---|---|
Journal, issue, pages | J. Med. Chem., Vol. 67, Page 1544-1562, Year 2024 |
Publish date | Dec 18, 2023 (structure data deposition date) |
Authors | Velcicky, J. / Janser, P. / Gommermann, N. / Brenneisen, S. / Ilic, S. / Vangrevelinghe, E. / Stiefl, N. / Boettcher, A. / Arnold, C. / Malinverni, C. ...Velcicky, J. / Janser, P. / Gommermann, N. / Brenneisen, S. / Ilic, S. / Vangrevelinghe, E. / Stiefl, N. / Boettcher, A. / Arnold, C. / Malinverni, C. / Dawson, J. / Murgasova, R. / Desrayaud, S. / Beltz, K. / Hinniger, A. / Dekker, C. / Farady, C.J. / Mackay, A. |
External links | J. Med. Chem. / PubMed:38175811 |
Methods | X-ray diffraction |
Resolution | 2.8 Å |
Structure data | PDB-8ri2: |
Chemicals | PDB-1h02: ChemComp-ADP: ChemComp-HOH: |
Source |
|
Keywords | IMMUNE SYSTEM / inflammasome / inhibitor / NLRP3 / NALP3 |